Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. laser-heal

LASER-HEAL

A breakthrough laser-based medical device to eradicate bacterial biofilm in chronic wounds and accelerate wound healing.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 LASER-HEAL project word cloud

Explore the words cloud of the LASER-HEAL project. It provides you a very rough idea of what is the project "LASER-HEAL" about.

delivering    confidential    income    commercialize    contours    mins    acquisition    care    solutions    laser    showing    gt    proposition    deep    29bn    10m    killing    epidemic    cells    sales    predicted    22    revenue    clinics    eradicate    markets    device    wound    time    fast    consists    antibiofilm    introduction    exit    software    intact    2024    2025    million    tackle    optomechatronics    approval    market    people    biofilms    session    backed    smei    move    game    successful    risked    72bn    cumulative    wounds    generating    confirm    preliminary    skin    lack    75    de    heal    first    safe    company    protecting    bn    chronic    data    seek    truly    abstract    solution    global    silent    human    2017    recognize    rapid    manner    obtaining    total    39bn    annual    regulatory    informa    treatment    map    standard    commercial    bacteria    left    medical    fda    invasive    pay    willingness    species    compatible    12    preferred    changing   

Project "LASER-HEAL" data sheet

The following table provides information about the project.

Coordinator		 VULCUR MEDTECH 

Organization address
address: SONDERVIGVEJ 50
city: VANLOSE
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Denmark [DK]
 Project website http://vulcur.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VULCUR MEDTECH DK (VANLOSE) coordinator 50˙000.00

Map

 Project objective

Chronic wounds affect 10M in Europe and 6.4 million people in the US, with annual costs of >€72Bn in Europe and >€22 Bn in the US. It is a silent epidemic. Key to this problem is the lack of truly effective solutions that fully eradicate bacteria-protecting biofilms deep within chronic wounds.

We have a game-changing new solution to tackle this problem: LASER-HEAL. LASER-HEAL is a medical device that consists of 1) a laser-generating unit that can reach deep within wounds; 2) optomechatronics to move the laser in a controlled manner and 3) software to recognize the contours and depth of wounds. LASER-HEAL enables, for the first time, non-invasive, safe, low-cost (€1.000 p/treatment), rapid (30 mins/session, total ~12) treatment, compatible with standard of care. We have preliminary data showing killing of all relevant species of bacteria, while human skin cells are left intact.

We will bring LASER-HEAL to the global wound care management market (€29bn in 2017 expected to reach €39bn by 2024). We will respond to the need of this market by delivering an effective antibiofilm device for chronic wounds. We will commercialize LASER-HEAL through sales to US clinics first, through fast FDA approval and confirm willingness to pay. By 2025, we will demonstrate revenue potential for LASER-HEAL, and seek a commercial exit, through acquisition (preferred) by a major medical device company, who will then bring LASER-HEAL to the European and global markets. Cumulative income of €75 million is predicted for LASER-HEAL by 2025 during this phase.

We have a unique proposition, backed by preliminary results and the interest of a major wound care company (confidential for this abstract). We want to undertake a detailed study to map successful market introduction for LASER-HEAL. Funding from SMEi Phase can support us with obtaining crucial market, regulatory and de-risked development informa

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LASER-HEAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LASER-HEAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

MACCO (2019)

Bring social robots into reality with the first real world leading bartender (MACCO)

Read More